RWIBX
Price
$62.90
Change
+$0.23 (+0.37%)
Updated
Apr 2 closing price
Net Assets
122.78B
VPRDX
Price
$16.08
Change
+$0.03 (+0.19%)
Updated
Apr 2 closing price
Net Assets
279.78M
Ad is loading...

RWIBX vs VPRDX

Header iconRWIBX vs VPRDX Comparison
Open Charts RWIBX vs VPRDXBanner chart's image
American Funds Capital World Gr&Inc R2
Price$62.90
Change+$0.23 (+0.37%)
VolumeN/A
Net Assets122.78B
VY® Morgan Stanley Global Franchise R6
Price$16.08
Change+$0.03 (+0.19%)
VolumeN/A
Net Assets279.78M
RWIBX vs VPRDX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RWIBX vs. VPRDX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RWIBX is a Buy and VPRDX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 123B vs. VPRDX (280M). RWIBX pays higher dividends than VPRDX: RWIBX (0.92) vs VPRDX (0.76). RWIBX was incepted earlier than VPRDX: RWIBX (23 years) vs VPRDX (9 years). RWIBX (1.51) is less costly to investors than VPRDX (0.98). RWIBX is a more actively managed with annual turnover of: 27.00 vs. VPRDX (15.00). VPRDX has a lower initial minimum investment than RWIBX: VPRDX (0) vs RWIBX (250). RWIBX annual gain was more profitable for investors over the last year : 0.05 vs. VPRDX (-0.73). RWIBX return over 5 years is better than : 64.01 vs. VPRDX (13.92).
RWIBXVPRDXRWIBX / VPRDX
Total Expense Ratio1.510.95159%
Annual Report Gross Expense Ratio1.510.98154%
Fund Existence23 years9 years-
Gain YTD0.6793.41520%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets123B280M43,929%
Annual Yield % from dividends0.920.76120%
Returns for 1 year0.05-0.73-6%
Returns for 3 years10.51-10.29-102%
Returns for 5 years64.0113.92460%
Returns for 10 years38.23N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APVO1.380.38
+38.26%
Aptevo Therapeutics Inc
LCTX0.440.03
+6.37%
Lineage Cell Therapeutics
BIO245.525.52
+2.30%
Bio-Rad Laboratories IncClass A
HLLY2.57N/A
N/A
Holley
TR31.29-0.28
-0.89%
Tootsie Roll Industries Inc